Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Lucid Diagnostics Inc. (LUCD)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 25

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eyenovia Inc. (EYEN)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 20

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 21

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aclarion Inc (ACON)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 29

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aclarion Inc (ACONW)

  • Technical Exchange News
  • Feb. 26, 2025, 02:44 UTC
  • 28

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Traws Pharma, Inc. (TRAW)

  • Technical Exchange News
  • Feb. 25, 2025, 18:49 UTC
  • 28

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Lucid Diagnostics Inc. (LUCD)

  • Technical Exchange News
  • Feb. 25, 2025, 18:48 UTC
  • 25

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eyenovia Inc. (EYEN)

  • Technical Exchange News
  • Feb. 25, 2025, 18:48 UTC
  • 28

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Feb. 25, 2025, 18:48 UTC
  • 22

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aclarion Inc (ACONW)

  • Technical Exchange News
  • Feb. 25, 2025, 18:48 UTC
  • 22

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 100
  • 101
  • 102
  • 103
  • 104
  • Next

Search

News categories

  • Technical Exchange News(9375)
  • Event(407)
  • SEC News(153222)
  • FDA Approval(8741)
  • Company Report(721)
  • Business News(104513)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin